Calif. Appeals Panel Revives Suits Over Diabetes Drugs
A California appeals court revived claims Tuesday that Merck & Co. and other diabetes drugmakers failed to warn about their drugs' pancreatic cancer risks, finding a lower court erred in not...To view the full article, register now.
Already a subscriber? Click here to view full article